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Abstract
Novel double-layer delivery devices based on soy protein derived materials were designed and produced using an innovative two material
co-injection moulding technique. It was demonstrated that the viscosity ratio between core and skin layer materials played an important role
in the formation of the interfacial shape, namely the skin thickness and uniformity of the bi-materials. The adequate selection of the materials
used and the optimisation of the respective processing conditions enabled an accurate control of the relative thickness of the layers of the
device. The preliminary results confirmed the potential of these systems to achieve a controlled drug delivery.
q 2003 Elsevier Ltd. All rights reserved.
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1. Introduction
In the past decades, numerous methodologies have been
investigated in order to produce controlled-release devices
presenting zero-order release kinetics over a prolonged
period of time [1–4]. These systems can maintain the drug
in the desired therapeutic range with just a single dose,
offering a number of advantages comparatively to the
conventional-release systems [5].
In terms of formulation, monolithic matrix devices (e.g.
tablets, particles, etc.) are widely used due to their easy
administration and low cost of manufacturing [6]. However,
these systems are incapable of attaining zero-order release,
exhibiting continuously diminishing delivery rates [7, 8].
The most common approach to overcome this problem and
to modify such type of release profiles is the restriction of
the exposed surface. This reduces the contact with the fluids
and is normally achieved by the addition of barrier layers.
The production of either multi-layer tablets (by partial
coating or compression coating) or core-shell particles (by
complex coacervation, freeze-drying, etc.) were attempted
by several research groups and have been extensively
investigated [9–16].
More recently, methods involving melt-based processing
techniques have also been described for the preparation of
this type of devices. The co-extrusion technology is a known
example [17]. A less conventional approach is based on a
two-material co-injection moulding technology. This tech-
nique allows the simultaneous moulding of two polymers
into the desired shape, without requiring further finishing
operations. The immediate result is a part with high
dimensional accuracy and adjustable skin-core morphology
[18]. Besides the economical advantages, the process offers:
(i) suitability for a large variety of polymeric matrices; (ii)
opportunity for simultaneous use of polymers of different
nature; (iii) precise control of the skin-core layers’ thickness
by adjustment of the processing parameters; and (iv) a good
interface between the two materials (if compatible matrices
are used) [19–21].
Therefore, co-injection moulding may allow for the
combination of a functional core material (with an
encapsulated bioactive agent) with a skin layer, which will
act as an effective barrier for the early drug diffusion. Since
it has been shown that it is possible to produce protein
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plastics using melt-based technologies, making cost-effec-
tive products feasible, soy protein was chosen as the
material for both matrices [22–25].
In fact, soy protein was selected because it can be
positively distinguished from other protein-like materials,
as it combines good melt processability [26,27], a reduced
susceptibility to thermal degradation [26,27], low moisture
sensitivity [28,29] and good storage stability [28,29].
This paper reports on the attempt to develop soy protein
double-layer controlled-release devices based on this non-
conventional approach. Consequently, a series of parts
involving several soy matrices were co-injection moulded
under optimised conditions. Rheological, mechanical and
structural analysis of the produced bi-material mouldings
are also presented and discussed in the manuscript.
2. Materials and methods
2.1. Materials
Soy protein isolate (amorphous, 83.4% protein, w/w on
dry weight base) containing 6% (w/w) water was purchased
from Loders Crocklaan BV, The Netherlands. Glycerol and
glyoxal (40% v/v) were used as received from the
manufacturer, Sigma-Aldrich Chemie BV (Zwijndrecht,
The Netherlands) used, respectively, as plasticizer and
crosslinker. The polymers were reinforced with a bone-like
ceramic filler hydroxylapatite (HA), namely a non-sintered
grade (CAM Implants, BV, Leiden, The Netherlands) with
an average particle size of 20 mm. This ceramic proved to
provide a bioactive character to soy matrices [23], important
attribute for materials aimed to be used in the biomedical
field.
A 50/50 wt% blend of corn starch with an ethylene–
vinyl alcohol copolymer (SEVA-C, Novamont, Novara,
Italy) was also used in this experiments for comparative
purposes.
The model drug, theophylline (C7H8N4O2), a xanthine
derivative with diuretic, cardiac stimulant and smooth
muscle relaxant activities, was obtained from Sigma-
Aldrich Chemie BV (Zwijndrecht, The Netherlands) with
a purity .98%.
All the other reagents used in the experiments were of
analytical grades.
2.2. Premix preparation
Premixes of the matrix material (soy protein isolate),
fillers and drug were prepared prior to processing. The
different compounds of the formulation were weighed and
transferred into a mixer container. For all the compounds,
the mixing operations were performed during 15 min at
room temperature (25 8C) using a mixer (Bear Varimixer,
Bear, Denmark) equipped with a low shear spiral-mixing
tool at a speed of 45 rpm.
2.3. Extrusion of the premix
The premixes were converted into plastic materials by
extrusion [27]. They were directly fed into a in a co-rotating
twin-screw extruder (Berstorff, Hannover, Germany,
D ¼ 25 mm and L ¼ 40D) and the liquids such as the
plasticizers (glycerol and water) and the crosslinker
(glyoxal) were concurrently injected into the feeding zone
of the extruder barrel with a piston pump (Pro Minet, Verder
BV, The Netherlands). The extrusion process was per-
formed at a screw speed of 200 rpm and barrel temperatures
ranging from 70 to 80 8C. When the processing was
complete, the extrudates were cooled to room temperature
and cut into pellets.
Table 1 presents the codes of all the compounds prepared
during this work, giving the respective formulations.
In the cases of the compounds SID and 0.6X-SID the
result was the direct production of soy plastics with
encapsulated theophylline drug.
The properties of the obtained compounds range from a
thermoplastic to a thermoset behaviour, depending on the
amount of crosslinking achieved during extrusion.
2.4. Capillary rheometry
The viscosity of the extruded compounds was measured
using a Rosand precision advanced capillary extrusion
rheometer, at 130 8C. All the tested materials presented
moisture content of 20 ^ 0.5%. The data was obtained
using a die of 1 mm radius and processed using the
Rabinowitsch correction. The entrance effects were taken
into account following the Bagley procedure.
2.5. Co-injection moulding
Axi-symmetrical dumbbell-like skin/core specimens of
1.5 mm of diameter (Fig. 1) were co-injection moulded in a
two material Ferromatik-Milacron K85 machine. This
machine is equipped with an 850 kN clamping unit and two
plasticating units oriented at an angle of 908 to each other. The
actions of the two units are independently controllable.
The machine was operated in mono-sandwich mode (Fig.
2). The injection moulding sequence includes: (i) the
Fig. 1. Sample cutting procedures.
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independent plastication of the two materials; (ii) the
extrusion of the material A (in the vertical unit) to the front
of the barrel of material B (step 1); and (iii) the simultaneous
injection of the two materials (step 2) due to the action of the
horizontal unit [19]. As material A goes in the front, it will
form the skin of the moulded part due to the contact with the
cold cavity walls. Material B flows within this skin, cooling
down under milder thermo-mechanical conditions and
forming the core of the part.
The selected moulding geometry and the high injection
velocities required to fill these bi-material specimens lead to
a very specific thermo-mechanical environment, being
expected high levels of heat dissipation. Shear rates during
the respective filling stages are around 2 £ 105 s21. This
particular situation reduced significantly the available
processing window and required an accurate optimisation
process.
The processing conditions used for the production of all
the mouldings are indicated in Table 2. The temperature
profiles of the two barrel units were, respectively: (i) vertical
unit: 140/130/120/115/110/30 8C; and (ii) horizontal unit:
140/150/145/140/135/30 8C.
Conventional injection moulding was also performed
with the SI, SI-30HA and SEVA-C materials for compara-
tive purposes.
2.6. Characterization of the mouldings
The SIs/SIDc, SIs/0.6X-SIDc, SI-30HAs/SIDc, SI-
30HSs/0.6X-SIDc and SEVA-Cs/SIDc bi-material mould-
ings were subsequently morphological and mechanically
characterized (the indices s and c refer to the skin and the
core materials, respectively).
2.6.1. Morphology
The mouldings morphology was assessed by observation
of the respective sections using an Olympus SZ-ET
stereoscope magnifier. The respective photographs were
taken using an Olympus DP 11 digital camera.
Two cutting procedures were used to section the
specimens as shown in Fig. 1. Procedure A consisted of
sections perpendicular to the flow direction in the HD-VD
plane. In procedure B, the mouldings were sectioned
parallel to the flow direction in the FD-VD plane, along
the centre of the specimen.
2.6.2. Mechanical properties
2.6.2.1. Tensile tests. The mechanical behaviour of the
specimens was assessed by means of tensile tests performed
on a Zwick Z010 universal mechanical testing machine
equipped with a 200 N static load cell. The selected
crosshead speed was 5 mm/min (corresponding to a strain
rate of 3.33 £ 1023 m s21). The deformation data was
obtained from a resistive extensometer. The E-modulus at
0.05–0.25% strain ðE0:05–0:25%Þ; the maximum tensile
strength ðsmaxÞ and the strain at break ðebÞ were evaluated.
The tensile tests were performed in a controlled environment
Table 1
Premix formulations in phg (parts per 100 g of soy)
Soy (SI) Glycerol (G) Water (W) Glyoxal (X) Theophylline (D) Hydroxylapatite (HA)
SI 100 10 35 – – –
SID 100 10 35 – 20 –
0.6X-SI 100 10 35 0.6 – –
0.6X-SID 100 10 35 0.6 20 –
SI-30HA 100 10 35 – – 30
Fig. 2. Mono-sandwich operation modes.
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(20 8C and 55% RH) equivalent to the atmosphere used for
conditioning the specimens during one week.
2.6.2.2. Moisture content. After testing, the fractured
samples were cryogenically ground in liquid nitrogen
using a Polymix A-10 (Switzerland) grinder. The ground
samples were sieved to obtain powders with particle sizes
,212 mm, which were weighed into aluminium dishes for
subsequent drying for 24 h in a vacuum oven at 40 8C [29].
Moisture content (MC) was determined in triplicate for each
type of material as percentage of the initial weight ðW0Þ lost
during drying ðW0dÞ :
MC ¼ W0 2W0d
W0
£ 100 ð1Þ
2.6.3. Preliminary release studies
The release kinetics of the model drug from a single-
layer device (SID) and a double-layer device (SIs/SIDc)
were studied after the parallel immersion of a sample of two
specimens. This was performed at 37 8C, in isotonic saline
solutions (ISS—NaCl, 9 g/l þ 1% sodium azide (NaN3))
buffered at pH 7.4 with 0.2 M Tris/HCl. At predetermined
times, 1 ml of every solution was taken out (and replaced by
1 ml of fresh solution) and assayed for released theophylline
(D) at 273 nm using an HPLC/UV Waters system. The
percentage of released drug was calculated from the
calibration curves previously established using different
theophylline standard solutions.
In order to characterize the release mechanisms associ-
ated to the different devices, a kinetic model (the Higuchi
equation) was applied to the release profiles (2),
Mt
M1
¼ k £ tn ð2Þ
where Mt=M1 is the cumulative amount of drug released at
time t; k the release constant (dependent on the surface areas
and the diffusion coefficient) and n the diffusional
coefficient [1,2,4].
3. Results and discussion
3.1. Rheological behaviour and morphology
It has been emphasized [19] that the viscosity ratio
between core and skin layer materials plays an important
role in the formation of the interfacial shape, namely the
skin thickness and uniformity.
The viscosity ðhÞ of the materials used in this study as a
function of shear rate ð _gÞ is presented in Fig. 3.
In Figs. 4 and 5 are presented the sandwich-like
morphology of the obtained moulding. Important differ-
ences in the relative thickness of the material layers as
function of the processing conditions and the selected pair
of compounds are apparent.
The skin ðSs=ScÞ and the viscosity ðhcÞ=ðhsÞ ratios were
calculated for all the mouldings and are shown in Fig. 6.
These results confirm the importance of the viscosity
ratio on the morphological development of the mouldings.
Consequently, the following discussion is based on this
parameter.
3.1.1. Condition 1: hchs
In this specific condition, the less viscous core melt
(SIDc) is able to penetrate deeper through the previously
formed skin material, as proved by its long flow lengths
observed in Fig. 4a and c). The layers distribution is uniform
and the skin thickness is relatively small (Fig. 4b and d).
However, this last parameter is mainly dependent on the
absolute magnitude of the viscosity of the skin material.
In fact, more viscous materials lead to the formation of
thicker skin layers [30], as confirmed by the results obtained
with compound SI-30HAs/SIDc, hs=hc ¼ 0:60 (Fig. 6). In
this case, the less viscous core will experience more
resistance to flow, as the effective flow section is reduced.
Therefore, the respective flow length observed is smaller
(Fig. 4c) when compared with the result obtained with the
less viscous skin material (e.g. SIs/SIDc, hs=hc ¼ 0:88) (Fig.
4a).
This type of behaviour is also followed by the SEVA-
Cs/SIDc specimens. The very high viscosity of the skin
material ðhðSIDcÞ=hðSEVA-CsÞ ¼ 0:48Þ inhibits the pen-
etration core melt, thus an increment of 10 m/s in the
injection speed was required (Table 2) to obtain the
Table 2
Co-injection moulding conditions
Materials V inj (mm/s) Pinj (bar) tinj (s) Q (cm
3/s) Skin:core ratio Tmould (8C)
SIs/SIDc 110 100 3.0 77.8 15/85 45
SIs/0.6X-SIDc 110 100 3.0 77.8 15/85 45
SI-30HAs/SIDc 110 100 3.0 77.8 15/85 45
SI-30HAs/0.6X-SIc 110 100 3.0 77.8 15/85 45
SEVA-Cs/SIDc 120 120 3.0 84.8 17.5/82.5 45
Pinj: injection pressure; V inj: injection speed; tinj: injection time; Q: flow rate.
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Fig. 3. Typical melt flow curves.
Fig. 4. Magnification of the optical sections of the mouldings: B–B0 (gate side): SIs/SIDc (a), SI-30HAs/SIDc (c) and SEVA-Cs/SIDc (e) A–A0: SIs/SIDc
(b), SI-30HAs/SIDc (d) and SEVA-Cs/SIDc (f).
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moulding shown in Fig. 4e. Consequently, a thicker skin is
also observed (Fig. 4e).
The central cross-sections (Fig. 4b, d and f) evidence the
geometrical homogeneity of the obtained devices (good
distribution of the core material through all part) and the
possibility to control the thickness of the diffusion barrier
layer (skin thickness). These are important characteristics
for a system aimed to be used as controlled drug delivery
device, since it can be easily tailored depending on the
requisites of the target application.
3.1.2. Condition 2: hchs
On a second condition, soy skin materials were
combined with a core compound of greater viscosity
(0.6X-SIDc).
The more viscous core melts (e.g. h(0.6X-SIDc)/-
h(SIDs) ¼ 1.49 and h(0.6X-SIDc)/h(SI-30HAs) ¼ 1.02)
(Fig. 6) experienced a higher flow difficulty, exhibiting
shorter flow lengths, as shown in Fig. 5a and c. Possibly, the
core materials tended to accumulate near the gate.
Conversely to the former condition (Section 3.1.1), these
Fig. 5. Magnification of the optical sections of the mouldings: B–B0 (gate side): SIs/0.6X-SIDc (a) and SI-30HAs/0.6X-SIDc (c) A–A0: SIs/0.6X-SIDc (b) and
SI-30HAs/0.6X-SIDc (d).
Fig. 6. Core/skin viscosity (hc/hs—V) and skin/core thickness (Ss/Sc—B) relationships of the double-layer materials.
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bi-material mouldings are characterized by a less uniform
distribution of the core and by a thicker skin (Fig. 5b and d).
3.2. Mechanical properties
The tensile properties (E-modulus, maximum strength
and strain at break) of the studied bi-materials are shown in
Fig. 7.
As expected, the mechanical properties of the double-
layer moulded specimens were found to be mainly
dependent on the performance of the core materials.
Consequently, the following analysis is associated to the
Fig. 7. Mechanical properties of the single- and double-layer moulded parts.
C.M. Vaz et al. / Polymer 44 (2003) 5983–5992 5989
type of core selected and based on the comparison with the
mono-material mouldings used as references.
3.2.1. Core 1: soy with encapsulated drug (SIDc)
Compared with the respective single-layer reference
parts (SI, SIHA and SEVA), the double-layer ones (SIs/-
SIDc, SI-30HAs/SIDc and SEVA-Cs/SIDc) presented an
increase in stiffness (between 11 and 20%) and in tensile
strength (5 and 30%) (Fig. 7a and b). This was followed by
an important decrease in the ductility, ranging from about
75% for SIs/SIDc to about 10% for SI-30HAs/SIDc and
SEVA-Cs/SIDc (Fig. 7c). These stiffness and strength
increments are related with the reinforcement effect of the
crystalline theophylline drug, present in 20 phg (parts per
hundred grams of soy) in the core material.
The decrement of ductility is the combined effect of three
factors: (i) the presence of the theophylline phase in the
polymer matrix; (ii) the decrease in moisture content; and
(iii) presence of a skin/core interface.
Although no lack of skin/core interfacial adhesion was
found in the morphological observations (Fig. 4), this type
of discontinuity in the bulk of the specimens is know to
reduce significantly the material ductility [21].
Comparatively to SIs/SIDc, the other bi-materials SI-
30HAs/SIDc and SEVA-Cs/SIDc present higher stiffness,
strength and brittleness (Fig. 7). This is also an expected
result that should be associated to the reinforcement effect
of the ceramic filler, hydroxylapatite (HA), (SI-30HAs/
SIDc) and to the higher rigidity of the starch based
compound (SEVA-Cs/SIDc) [31,32].
3.2.2. Core 2: glyoxal crosslinked-soy with encapsulated
drug (0.6X-SIDc)
The use of crosslinked soy with encapsulated theophyl-
line in the core results in double-layer parts (SIs/0.6X-SIDc
and SI-30HAs/0.6X-SIDc) presenting lower values of the
tensile strength and ductility relatively to the reference
materials (Fig. 7b and c). The variations in the stiffness are
negligible relatively to the reference materials, but a
decrease is observed when compared with the non-
crosslinked compounds (Fig. 7a).
The significant reduction in the tensile strength (from 20
to 26%, relatively to non-crosslinked materials) (Fig. 7b) is
the combined result of two factors: (i) the lower core
thickness of this group of mouldings; and (ii) the lower
strength of the glyoxal cross-linked soy plastics.
In fact, it is already known [24] that due to the intra-
molecular nature of the crosslinking reaction between
glyoxal and soy proteins, the resulting highly crosslinked
core materials are characterized by a much lower chain
mobility and, consequently, higher sensitivity to thermal-
degradation during processing.
3.3. Release behaviour
A preliminary test was performed to compare the
efficiency between a single-layer and a double-layer device
to attain a zero-order release.
Fig. 8 presents the release profile of theophylline in an
isotonic saline solution over a 6000 min study from a single
(SID) and a double-layered (SIs/SIDc) specimens.
The single delivery device SID is mainly characterized
Fig. 7 (continued )
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by an initial burst (Fig. 8). When the fraction released of
theophylline is plotted against time on a log–log scale, the
diffusional exponent value n is 0.50. This indicates that
theophylline releases from the soy matrix following Fickian
diffusion mechanism at a release rate ðkÞ of
0.052 ^ 0.012 mg min21 (0.87 mg s21)
However, a controlled drug release was observed when a
diffusion retardant layer SIs was used (Fig. 8). Accordingly
to these results, the skin barrier layer produced by co-
injection was able to delay the interaction of the core
material with the dissolution medium. This layer proved to
be efficient in reducing the surface available for drug release
and in limiting the solvent penetration rate. Thus, the burst
effect observed in the single part could be now controlled
and the area available for drug release could be maintained
at a relatively constant level. The final result is a device with
potential application in the biomedical field as a controlled
drug delivery device (slow release/fast release).
4. Conclusions
Prototype double-layer drug delivery devices have been
designed and produced using a non-standard protein-based
matrix and an innovative technique in the field, co-injection
moulding. This study confirms the potential of these systems
to achieve a controlled drug delivery. The adequate
selection of the materials used and the optimisation of the
respective processing conditions enable an accurate control
of the relative thickness of the layers of the device.
The higher intricacy of these devices leads to more
complex release mechanisms that need to be further
evaluated in the future.
References
[1] Colombo P, Conte U, Gazzaniga A, Maggi L, Sangalli ME, Peppas
NA, La Mannas A. Int J Pharm 1990;63:43–8.
[2] Colombo P, Catellani P, Peppas NA, Maggi L, Conte U. Int J Pharm
1992;88:99–109.
[3] Qiu Y, Chidambaram N, Flood K. J Control Rel 1998;51:123–30.
[4] Chidambaram N, Porter W, Flood K, Qiu Y. J Control Rel 1998;52:
149–58.
[5] Parker RS, Doyle IIIFJ. Adv Drug Deliv Rev 2001;48:211–28.
[6] Danckwerts MP. Int J Pharm 1994;112:37–45.
[7] Siepmann J, Podual K, Sriwongjanya M, Peppas. Pharm Res 1999;16:
1748–56.
[8] Siepmann J, Podual K, Sriwongjanya M, Peppas NA, Bodmeier R.
J Pharm Sci 1999;88:65–72.
[9] Yang L, Fassihi R. Int J Pharm 1999;155:219–29.
[10] Zhou T, Lewis H, Foster RE, Schwendeman S. J Control Rel 1998;55:
281–95.
[11] Ndindayino F, Vervaet C, van den Mooter G, Remon JP. Int J Pharm
2002;235:159–68.
[12] Yang L, Fassihi R. J Pharm Sci 1996;85(2):170–3.
[13] Remun˜a´n-Lo´pez C, Portero A, Vila-Jato JL, Alonso MJ. J Control Rel
1998;55:143–52.
[14] Jeong Y-I, Cheon J-B, Kim S-H, Nah J-W, Lee Y-M, Sung Y-K,
Akaike T, Cho C-S. J Control Rel 1998;51:169–78.
[15] Sousa JJ, Sousa A, Moura MJ, Podczeck F, Newton JM. Int J Pharm
2002;233:111–22.
[16] Charalambopoulou G, Kikkinides ES, Papadokostaki KG, Stubos AK,
Papaioannou ATh. J Control Rel 2001;70:309–19.
[17] Washburn NR, Simon Jr CG, Tona A, Elgendy HM, Karim A, Amis
EJ. J Biomed Mater Res 2002;60(1):20–9.
[18] Eckardt H. J Cell Plast 1987;5:23–7.
[19] Kadota M, Cakmak M, Hamada H. Polymer 1999;40:3119–45.
[20] Selden R. Polym Engng Sci 2000;40(5):1165–76.
Fig. 8. Comparison between the release profiles of a single- and a double-layer device.
C.M. Vaz et al. / Polymer 44 (2003) 5983–5992 5991
[21] Bichler M, Klotz B. Kunststoffe Plast Eur 1997;October:13–16.
[22] Vaz CM, Fossen M, van Tuil RF, de Graaf LA, Reis RL, Cunha AM.
J Macromol Sci Phys 2002;B41:33–46.
[23] Vaz CM, Fossen M, Tuil RF, de Graaf LA, Reis RL, Cunha AM.
J Biomed Mater Res 2003;65A:60–70.
[24] Vaz CM, de Graaf LA, Reis RL, Cunha AM. Soy protein-based
systems for different tissue regeneration applications. In: Reis RL,
Cohn D, editors. Polymer based systems on tissue engineering,
replacement and regeneration, vol. 86. Dordrecht: Kluwer Academic;
2003. p. 93–110.
[25] Vaz CM, de Graaf LA, Mulder WF. Adhesives, coatings and
bioplastics from protein sources. In: Steinbuchel A, Fahnestock SR,
editors. Biopolymers: polyamides and complex proteinaceous
materials II, vol. 8. Weinheim: Wiley-VCH; 2003.
[26] Sheard PR, Mitchell JR, Ledward DA. J Food Tech 1986;21:627–41.
[27] Ferreira SHP, Areˆas JAG. J Food Sci 1993;58:378–81.
[28] Paetau I, Chen C-Z, Jane J. Ind Engng Chem Res 1994;33:1821–7.
[29] Wang S, Sue H-J, Jane J. J Mater Sci-Pure Appl Chem 1996;A33:
557–69.
[30] Brito AM, Cunha AM. Int Polym Proc 1991;VI(4):370–7.
[31] Reis RL, Cunha AM. J Mat Sci: Mater Med 1995;6:786–90.
[32] Reis RL, Mendes SC, Cunha AM, Bevis MJ. Polym Int 1997;43:
347–52.
C.M. Vaz et al. / Polymer 44 (2003) 5983–59925992
